Chinese and Western medicine treatment of chronic myeloid leukemia with new progress.docVIP

 PAGE \* MERGEFORMAT 21 Chinese and Western medicine treatment of chronic myeloid leukemia with new progress Author: Deng Jian-Ping Shen Shu Shen Yi-Ping Zhou Yuhong Abstract In recent years, chronic myeloid leukemia (CML) in the treatment of Chinese and Western medicine on the basis of past progress has been made for development of BCR  ABL tyrosine kinase inhibitors, targeted therapy is the focus of CML, bone marrow transplant is the best way to treat CML, and with the signal transduction pathway of CML in-depth study of individual treatment will also be possible. The Chinese understanding of the disease Gejia different, but none from the empty, poison or stasis three links. Keywords: chronic myeloid leukemia; hydroxy-urea; molecular target; of hematopoietic stem cell transplantation; traditional Chinese medicine; Review Abstract: In recent years, CML treated with combination of TCM and WM has got great achievement on the basis of before.Pointing to the emphasis that the inhibitor of BCR  ABL tyrosine kinases is the target treatment of CML, and marrow transplantation is the most ideal method for CML, meanwhile, with further research on CML signal transmitting route, individualized treatment will be possible.Though every expert has his own idea to the disease from TCM, it still concerns 3 links of deficiency, toxin and stasis. Keywords:: CML; hydroxyacrbamide; molecular target; transplantation of blood  producing dry cell; TCM therapy; review Chronic myeloid leukemia (CML) is a hematopoietic stem cell clone proliferative diseases, bone marrow with granulocyte hyperplasia, peripheral leukocytosis, and splenomegaly as the main feature. Over 90% of patients present in bone marrow cells characteristic of the Philadelphia chromosome (ph chromosomes) and / or BCR / ABL fusion gene. The median survival period of 3 to 4 years, the global annual incidence rate of about 1 / 10 million, representing about 15% of adult